SAB Biotherapeutics, Inc. (SABSW) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | $13.27M | +138.9% |
| 2024 | -$34.11M | +19.2% |
| 2023 | -$42.19M | -125.1% |
| 2022 | -$18.74M | -9.3% |
| 2021 | -$17.14M | -185.2% |
| 2020 | $20.12M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | $13.27M | +138.9% |
| 2024 | -$34.11M | +19.2% |
| 2023 | -$42.19M | -125.1% |
| 2022 | -$18.74M | -9.3% |
| 2021 | -$17.14M | -185.2% |
| 2020 | $20.12M | — |